Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$56.95+1.58 (+2.85%)
Close on Nov 18, 2026Market cap $3.40BP/E –Yield –
Axogen operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Axogen's operating income for the twelve months ending Sep 30, 2026 was -$13.81M, down 450.4% year over year. For fiscal 2025 it was -$7.85M. The highest annual figure on record is -$3.29M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.85M | – |
| FY2024 | Dec 31, 2024 | -$3.29M | – |
| FY2023 | Dec 31, 2023 | -$21.46M | – |
| FY2022 | Dec 31, 2022 | -$29.71M | – |
| FY2021 | Dec 31, 2021 | -$25.42M | – |
| FY2020 | Dec 31, 2020 | -$23.18M | – |
| FY2019 | Dec 31, 2019 | -$31.41M | – |
| FY2018 | Dec 31, 2018 | -$20.50M | – |
| FY2017 | Dec 31, 2017 | -$7.95M | – |
| FY2016 | Dec 31, 2016 | -$8.13M | – |
| FY2015 | Dec 31, 2015 | -$9.27M | – |
| FY2014 | Dec 31, 2014 | -$9.80M | – |
| FY2013 | Dec 31, 2013 | -$9.59M | – |
| FY2012 | Dec 31, 2012 | -$7.80M | – |
| FY2011 | Dec 31, 2011 | -$6.97M | – |
| FY2010 | Dec 31, 2010 | -$4.48M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $955.00K | -50.1% |
| Q2 FY2026 | Jun 30, 2026 | -$2.16M | -228.9% |
| Q1 FY2026 | Mar 31, 2026 | -$2.83M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.77M | -584.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.91M | – |
| Q2 FY2025 | Jun 30, 2025 | $1.67M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.66M | – |
| Q4 FY2024 | Dec 31, 2024 | $2.02M | – |
| Q3 FY2024 | Sep 30, 2024 | -$316.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$428.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.56M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.19M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.03M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.90M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.34M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.61M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.86M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.92M | – |
| Q1 FY2022 | Mar 31, 2022 | -$11.32M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.35M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.69M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.15M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.37M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.05M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.51M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.42M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.11M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.67M | – |
| Q1 FY2019 | Mar 31, 2019 | -$10.20M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.86M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.84M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.82M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.99M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.81M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.50M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.45M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.20M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.72M | – |
See a number that looks wrong?